Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2025-07-03 00:00:00 ET · period of report 2025-07-01 · accession 0000950170-25-094002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2025-07-03 | 2025-07-01+ | BEAM | Simon Amy | Chief Medical Off | S - Sale | $19.17 | -1,250 | 64.9K | -2% | -$24.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-01 | S | D | 374 | $16.94 | 65,740 | D | — | — | (F2) Includes 372 shares acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2024. |
| 2 | Common | Common Stock | 2025-07-03 | S | D | 876 | $20.12 | 64,864 | D | — | — |